2019年美国经导管心血管治疗研讨会/年会(TCT2019) 已截止报名
推荐参加：十五五重点课题前期研究谋划暨2025年国家科技项目申报和科研平台建设运行、科研资金全过程管理使用高级研修班(1月上海)

会议时间： 2019-09-25 09:00至 2019-09-29 18:00结束

会议地点：旧金山详细地址会前通知 None 周边酒店预订

主办单位：美国心血管研究基金会(CRF)

行业热销热门关注看了又看换一换

会议内容

◆ 会议时间：2019年9月25-29目
◆ 会议地点：美国旧金山（San Francisco）

◆ 会议简介：

美国经导管心血管治疗学术会议（TCT）是CRF主办的世界上规模最大、最重要的专注于心血管介入医学的教育会议。30年来，TCT通过提供前沿的教育内容、展示当前治疗和临床研究的最新进展，来提高目标受众群体的能力实践。TCT科学研讨会的与会者包括：介入心脏病专家、放射科医师、临床心脏病专家、科学家，血管医学专家、心脏和血管外科医生、护士、导管室技师和其他介入和血管医学领域的相关人士等。2018年TCT科学研讨会预计有来自全球100多个国家的10000余名专业人士参会。

美国心血管研究基金会(CRF)成立于1991年，是一个致力于改善世界各地心脏病患者生存和生活质量的非营利组织。CRF在介入心血管医学中安全地使用新技术、药物等手段治疗心脏与血管疾病方面发挥了重要的作用。CRF教育中心每年举办超过50个教育会议和大会，包括年度经导管心血管治疗（TCT）科学研讨会，为相关人员提供前沿技术和创新等方面的培训。

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.

摘要提交：
ABSTRACTS
Submission Opens: Tuesday, March 5, 2019
Submission Deadline: Tuesday, June 4, 2019 (2:00 PM, ET)
Abstract submissions should address an area of interventional cardiology, endovascular medicine, or structural heart disease and constitute original research, but may include portions of prior abstracts and/or manuscripts presented elsewhere. Clinical studies, basic science investigation, and preclinical studies are equally encouraged. Reports of a single patient should be submitted to Challenging Cases, regardless of the novelty of the individual case.

LATE-BREAKING CLINICAL TRIALS AND SCIENCE
Submission Opens: Tuesday, February 26, 2019
Submission Deadline: Monday, July 8, 2019 (2:00 PM, ET)
Late-Breaking Clinical Trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials or of large-scale, impactful single-center or multicenter registries.

Late-Breaking Clinical Science submissions are the first worldwide presentations of smaller randomized trials, impactful single-center or multicenter registries, or first-in-man experiences with novel devices or drugs. Accepted submissions will be presented in the Main Arena at TCT 2019, and during press conferences scheduled on the same days as the Main Arena presentations.

The following rarely qualify as Late-Breaking Clinical Trial submissions: preclinical studies, early first-in-human device studies, and meta-analyses; these should be submitted as Abstracts or as Interventional Innovations.

CALL FOR FASCINATING LECTURES
Submission Opens: Monday, March 4, 2019
Submission Deadline: Tuesday, May 14, 2019 (2:00 PM, ET)
TCT is always looking to present fascinating and futuristic concepts and ideas that relate to improving outcomes for patients with cardiovascular disease.

Submit your ideas for an interesting lecture you would like to present that is not typical for large CV congresses.

Examples might include: digital health, machine learning, artificial intelligence, micro-imaging breakthroughs, regionalized systems of care, nano-technologies, regulatory reform, role of social media, fetal therapies for prevention, etc. Anything novel will be considered!

CHALLENGING CASES
Submission Opens: Tuesday, April 2, 2019
Submission Deadline: Thursday, June 20, 2019 (2:00 PM, ET)
Physicians from around the world are invited to submit their most challenging coronary, endovascular, and structural heart disease cases. The directors of TCT review each submitted case and select the best for presentation.

TCT 2019 注册费：

TCT Full Conference	Early Registration Thursday, May 30, 2019 (11:59 PM ET)	Advance Registration Friday, May 31(12:00 AM ET) toTuesday, August 6, 2019 (11:59 PM ET)	On-site Registration Wednesday, August 7, 2019(12:00 AM ET) and Onward
Physician	$995.00	$995.00	$1,695.00
US Fellow++	$0	$0	$0
International Fellow++	$0	$0	$0
Allied Health Professional	$300.00	$300.00	$400.00
Industry Professional	$1,699.00	$1,799.00	$1,949.00
US Government Official+	$160.00	$199.00	$229.00

◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。

※相关服务※
会议注册服务：50美金/人/次，大会注册费按官方规定收取；
出境签证服务：1500元人民币/人/次（美国，含签证费），其它国家咨询客服；
大会投稿服务：30美金/人/次，官方收取费用另计（如有）；
会员申请服务：30-100美金/人/次；
代订展位服务：服务费为展位费用×10%；

团组参会、境外游览、医学考察、境外研修、商务出行等，请直接联系客服。

声明：

1、以上会议非活动家网站主办或承办会议，活动家网站学术会议频道会议信息来自于互联网，方便用户了解行业信息，如需参会、报名、获取会议邀请函或会议日程，请直接与学术会议活动主办单位联系。

2、部分会议内容来自互联网，由于网络的不确定性，活动家网站对所发布的信息不承担真实性的鉴别工作，请谨慎选择。若您发现会议页面信息有误，请联系活动家客服028-69761252纠错。

3、欢迎各行业学术会议举办方在活动家网站自行发布学术会议信息，发布活动请点击发布活动。

主办方：美国心血管研究基金会(CRF)

介绍：美国心血管研究基金会(CRF) 于2019年9月25日举行2019年美国经导管心血管治疗研讨会/年会(TCT2019)。

温馨提示
酒店与住宿: 为防止极端情况下活动延期或取消，建议“异地客户”与活动家客服确认参会信息后，再安排出行与住宿。
退款规则: 活动各项资源需提前采购，购票后不支持退款，可以换人参加。